Ascendant Solutions (OTCMKTS:MYDP) versus GeneDx (NASDAQ:WGS) Critical Analysis

Ascendant Solutions (OTCMKTS:MYDP) and GeneDx (NASDAQ:WGS) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, risk, institutional ownership and earnings.

Insider and Institutional Ownership

61.7% of GeneDx shares are held by institutional investors. 31.6% of Ascendant Solutions shares are held by company insiders. Comparatively, 29.6% of GeneDx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Ascendant Solutions and GeneDx, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ascendant Solutions	0	0	0	0	0.00
GeneDx	0	2	6	0	2.75

GeneDx has a consensus price target of $101.6250, indicating a potential downside of 17.45%. Given GeneDx’s stronger consensus rating and higher probable upside, analysts clearly believe GeneDx is more favorable than Ascendant Solutions.

Profitability

This table compares Ascendant Solutions and GeneDx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ascendant Solutions	N/A	N/A	N/A
GeneDx	0.39%	16.51%	9.35%

Earnings and Valuation

This table compares Ascendant Solutions and GeneDx”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ascendant Solutions	N/A	N/A	N/A	N/A	N/A
GeneDx	$305.45 million	11.58	-$52.29 million	$0.05	2,462.20

Ascendant Solutions has higher earnings, but lower revenue than GeneDx.

Summary

GeneDx beats Ascendant Solutions on 8 of the 9 factors compared between the two stocks.

About Ascendant Solutions

Dougherty's Pharmacy, Inc. focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty's Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty's Pharmacy, Inc. in May 2017. Dougherty's Pharmacy, Inc. was founded in 1929 and is based in Dallas, Texas.

About GeneDx

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.